Haemorrhagic Complications of Vitamin K Antagonists in the Elderly: Risk Factors and Management

ISSN： 1170-229X

Source： Drugs & Aging, Vol.23, Iss.1, 2006-01, pp. : 13-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Careful management can reduce the risk of bleeding in elderly patients receiving vitamin K antagonist (VKA) therapy

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 22, Iss. 12, 2006-12 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Management of haemorrhagic complications associated with oral anticoagulant treatment

By Beyth Rebecca J

Expert Opinion on Drug Safety, Vol. 1, Iss. 2, 2002-07 ,pp. : 129-136

Informa Healthcare

Access to resources Recommend Favorite

Dabigatran etexilate: Haemorrhagic complications in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1434, 2013-01 ,pp. : 20-21

Adis International

Access to resources Recommend Favorite

Vitamin K antagonists associated with arterial calcinosis

Reactions Weekly, Vol. 1, Iss. 1258, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

QOL effect of treatment duration with vitamin K antagonists

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 430, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite